UCI Health will see you now: Welcome to our new co-workers and patients from Fountain Valley, Lakewood, Los Alamitos and Placentia-Linda!
Read more about our recent acquisition.

Heart disease risk can indicate long-term COPD fate, UCI Health researchers say

Findings underline importance of cardiac testing in lung disease prognosis, treatment

May 02, 2012
Nathan Wong COPD

A simple test for heart disease risk can go a long way toward determining the long-term prognosis for people with chronic obstructive pulmonary disease, according to UC Irvine researchers.

Dr. Hwa Mu Lee and Nathan Wong of the UC Irvine Heart Disease Prevention Program found that individuals with moderate to severe COPD who had a low Framingham Heart Study 10-year risk assessment rate lived longer and healthier than COPD patients who scored high on the heart test.

Study results point to the importance of cardiovascular health for those with COPD and strongly suggest that heart disease risk evaluations be part of the diagnostic and treatment procedures for lung diseases such as emphysema and bronchitis that affect 64 million people worldwide and are the third-leading cause of death in the U.S.

“There is a close connection between COPD and cardiovascular events like heart attacks, but too often physicians who see COPD patients do not assess the impact of heart disease risk factors as part of a treatment plan,” said Lee, associate research director of the UC Irvine program and clinical professor in the Division of Pulmonary Diseases and Critical Care Medicine.

“We’re learning that addressing cardiac risk factors may significantly improve outcomes in persons with COPD,” added Wong, program director and a professor of cardiology and epidemiology. “The connection between these two diseases is underappreciated.”

Lee and Wong examined the severity of COPD in 6,266 U.S. adults over 40 in relation to their 10-year cardiovascular disease risk, which can be estimated by the Framingham Heart Study’s risk calculator.

They noted that there are current National Institutes of Health-funded studies on whether statins—cholesterol-lowering drugs often prescribed for heart patients—can help lessen COPD-related lung inflammation.

Janet Lee, Katherine Lee and Yanting Luo of UC Irvine, as well as Dr. Don Sin of St. Paul’s Hospital in Vancouver, also contributed to the study, which appears online in the journal Chest.

About the University of California, Irvine: Founded in 1965, UC Irvine is a top-ranked university dedicated to research, scholarship and community service. Led by Chancellor Michael Drake since 2005, UC Irvine is among the most dynamic campuses in the University of California system, with nearly 28,000 undergraduate and graduate students, 1,100 faculty and 9,000 staff. Orange County’s second-largest employer, UC Irvine contributes an annual economic impact of $4 billion. For more UC Irvine news, visit news.uci.edu.

News Radio: UC Irvine maintains on campus an ISDN line for conducting interviews with its faculty and experts. Use of this line is available for a fee to radio news programs/stations that wish to interview UC Irvine faculty and experts. Use of the ISDN line is subject to availability and approval by the university.